See more : MoneyOnMobile, Inc. (MOMT) Income Statement Analysis – Financial Results
Complete financial analysis of Titan Medical Inc. (TMDI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Titan Medical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- NIPPON PARKING DEVELOPMENT Co.,Ltd. (2353.T) Income Statement Analysis – Financial Results
- Seres Therapeutics, Inc. (MCRB) Income Statement Analysis – Financial Results
- Canadian Metals Inc. (CME.CN) Income Statement Analysis – Financial Results
- ViviCells International, Inc. (VCII) Income Statement Analysis – Financial Results
- Oi Wah Pawnshop Credit Holdings Limited (1319.HK) Income Statement Analysis – Financial Results
Titan Medical Inc. (TMDI)
About Titan Medical Inc.
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.09M | 20.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 58.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 20.09M | 20.00M | -58.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 37.96M | 7.94M | 51.42M | 32.86M | 12.90M | 22.58M | 38.21M | 10.68M | 5.35M | 4.64M | 12.48M | 1.57M | 158.77K | 1.44M | 150.91K |
| General & Administrative | 12.43M | 7.49M | 7.81M | 6.80M | 5.97M | 4.93M | 3.53M | 3.50M | 3.48M | 3.08M | 3.07M | 1.97M | 548.18K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 140.98K | -5.00 | 2.00 | 1.00 | -5.00 | 1.00 | -4.00 | -114.22K | 9.82K | 240.83K | 134.87K | 11.76K | 0.00 | 0.00 |
| SG&A | 12.43M | 7.63M | 7.81M | 6.80M | 5.97M | 4.93M | 3.53M | 3.50M | 3.37M | 3.09M | 3.31M | 2.11M | 559.94K | 692.32K | 132.00K |
| Other Expenses | 699.00K | 0.00 | 32.55K | 29.04K | 17.36K | 24.64K | 32.39K | 23.66K | 118.75K | 155.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 51.08M | 15.57M | 59.27M | 39.69M | 18.88M | 27.53M | 41.77M | 14.20M | 8.83M | 7.88M | 15.79M | 3.68M | 718.71K | 2.13M | 282.91K |
| Cost & Expenses | 51.08M | 15.80M | 59.73M | 38.71M | 19.43M | 27.81M | 42.64M | 14.77M | 9.13M | 7.85M | 15.89M | 3.72M | 741.82K | 2.15M | 303.09K |
| Interest Income | 73.00K | 29.14K | 115.58K | 288.30K | 17.44K | 7.54K | 88.64K | 305.29K | 59.16K | 87.26K | 93.11K | 33.80K | 28.16K | 16.69K | 0.00 |
| Interest Expense | 125.00K | 1.09M | 422.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 165.48K | 27.57K |
| Depreciation & Amortization | 699.00K | 236.84K | 32.56K | 29.04K | 17.36K | 24.64K | 32.39K | 23.66K | 289.47K | 132.65K | 95.68K | 41.41K | 23.11K | 19.19K | 20.19K |
| EBITDA | -13.98M | -22.86M | -41.45M | -22.61M | -33.57M | -23.30M | -41.38M | -13.43M | -8.78M | -7.63M | -15.70M | -3.65M | -690.55K | -2.12M | -282.91K |
| EBITDA Ratio | -69.57% | -114.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.68M | -23.09M | -41.48M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | -15.80M | -3.69M | -713.66K | -2.14M | -303.09K |
| Operating Income Ratio | -73.05% | -115.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 16.19M | -1.09M | 10.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -14.80M | -24.18M | -41.91M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -73.67% | -120.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 56.00K | 1.09M | 422.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 165.48K | 27.57K |
| Net Income | -14.86M | -25.28M | -42.33M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | -15.80M | -3.69M | -713.66K | -2.30M | -330.66K |
| Net Income Ratio | -73.95% | -126.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.22 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.87 | -3.63 | -8.73 | -2.58 | -0.64 | -2.94 | -8.50 |
| EPS Diluted | -0.22 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.87 | -3.63 | -8.73 | -2.58 | -0.64 | -2.94 | -8.50 |
| Weighted Avg Shares Out | 67.01M | 67.01M | 30.69M | 16.64M | 7.90M | 4.89M | 3.48M | 3.14M | 2.34M | 2.14M | 1.81M | 1.43M | 1.11M | 782.20K | 38.89K |
| Weighted Avg Shares Out (Dil) | 67.01M | 67.01M | 30.69M | 16.64M | 7.90M | 4.89M | 3.48M | 3.14M | 2.34M | 2.14M | 1.81M | 1.43M | 1.11M | 782.20K | 38.89K |
Titan Medical Inc. (TMDI) CEO David McNally on Q4 2020 Results - Earnings Call Transcript
Titan Medical Inc. (TMDI) CEO David McNally on Q4 2020 Results - Earnings Call Transcript
Titan Medical Reports Year-End 2020 Financial Results
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the release of its annual financial results for...
Titan Medical Announces Filing of Final Short Form Prospectus
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed and been receipted for a final...
Titan Medical to Report Year-End 2020 Financial Results and Host Webcast on February 22, 2021
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company plans to issue its fourth quarter...
Titan Medical Announces Filing of Preliminary Short Form Prospectus
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed a preliminary short form...
Titan Medical Announces Upsize to Previously Announced Bought Deal Offering
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc....
Titan Medical Announces Us $15 Million Bought Deal Offering
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc....
Titan Medical Announces Closing of US $11.5M Bought Deal Offering Including Full Exercise of Over-Allotment Option
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it closed its previously announced offering of...
Titan Medical Announces Filing of Final Short Form Prospectus
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed and been receipted for...
Titan Medical Announces Filing of Preliminary Short Form Prospectus
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed a preliminary short form...
Source: https://incomestatements.info
Category: Stock Reports